NEW YORK (GenomeWeb News) – Applied Biosystems and Integromics have worked together to integrate their data handling and PCR systems for biomarker analysis, drug development, and clinical studies, ABI said today.
The companies have integrated ABI’s TaqMan arrays and real-time PCR systems with Integromics StatMiner software, which combines data visualization functions with statistical analysis and data mining tools, for use in analyzing real-time gene expression data from biomarker research.
ABI and Integromics began the development and co-marketing project, which included assistance from Novartis Pharma, in December 2007.
ABI said Novartis is working to promote gene expression biomarkers in drug development studies, and recently used ABI’s TaqMan arrays in a large-scale pilot study.
The integrated products support “customers such as Novartis in their gene expression research, by enabling them to turn their data into meaningful information for use in a range of research projects including drug discovery and development,” Xavier Cristina, Applied Biosystems’ European manager for business development in functional analysis, said in a statement.